medical service | Tokio X'press - Part 60

COVID-19：イベルメクチン､ランダム化二重盲検治験：イスラエルSheba（動画）：　 Randomized Double-Blinded Trial at Sheba Medical Center:Ivermectin：　舍巴医学中心的随机双盲临床试验：伊维菌素可从本质上降低COVID-19

2021年02月18日By Tokio X'press flu, Product Safety & Quality, Insuring Health & Demographic Risk, Opportunities in Nutrition & Health, Business Ethics, Pharmaceutical

大阪大：ｉＰＳで目の結膜細胞作製：ドライアイの創薬に期待（動画）：　 Osaka Univ: Making eye conjunctival cells with iPS: for drug of dry eye: 大阪大学：使用iPS制作眼结膜细胞：对干眼症药物发现的期望

2021年02月15日By Tokio X'press Health & Safety, 1.Product Liability, Product Safety & Quality, Access to Health Care, Opportunities in Nutrition & Health, IPS, Medical science, Pharmaceutical

堀場：米試薬メーカー買収：MedTest Dx ・Pointe Scientific（動画）：　 HORIBA: Acquired US reagent manufact: MedTest Dx ・ Pointe Scientific：　 HORI场：被收购的美国试剂制造商：MedTest Dx ・ Pointe Scientific

2021年02月14日By Tokio X'press Health & Safety, 1.Product Liability, Product Safety & Quality, Access to Health Care, Medical science, monitor

COVID-19： Appili､米国でファビピラビル治験：第3相試験募集（動画）：　 Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir：　 Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新

2021年02月12日By Tokio X'press flu, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical

COVID-19：ロボットでPCR検査数を大幅増：川崎重工が開発（動画）：　 COVID-19: Significantly increase the PCR tests with robots: by KHI：　 COVID-19：大大增加了机器人进行PCR测试的次数：由川崎重工开发

2021年02月10日By Tokio X'press flu, 0.Pollution & Waste, 1.Human Capital, Labor Management, Health & Safety, Product Safety & Quality, monitor, medical service

1 … 59 60 61 … 181